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Background
Precondition for activation and aggregation of platelets
is a rise in intracellular calcium concentration which
can be inhibited by activation of the NO/cGMP/cGKI
signalling cascade. The cGMP-dependent Kinase I
(cGKI) is assembled in a macrocomplex with the Inosi-
toltrisphosphate receptor I (InsP3R-I) and the Inositoltri-
sphosphate receptor associated cGMP kinase substrate
(IRAG).
Results
We investigated the relevance of IRAG and the cGKI
stimulated phosphorylation of the calcium channel
InsP3R-I for the NO/cGMP-dependent inhibition of pla-
telet aggregation and adhesion.
After incubation with different agonists (collagen,
thrombin, TxA2) we performed aggregation experiments
with platelets of WT and IRAG-KO mice, thereby the
IRAG-KO platelets aggregated stronger than the WT
platelets. After preincubation with NO/cGMP the inhi-
bition of aggregation was decreased in IRAG-KO plate-
lets compared to WT platelets. Furthermore, GPIIb/IIIa-
mediated adhesion of platelets to fibrinogen could only
weakly be inhibited in IRAG-deficient platelets contrary
to WT platelets. The cGKI-mediated stimulation of
InsP3R-I phosphorylation showed an equal increase in
WT and IRAG-KO platelets.
Conclusion
These results revealed that IRAG plays an important
role in the NO/cGMP-dependent inhibition of platelet
aggregation. However, the cGMP-stimulated phosphory-
lation of InsP3R-I is not necessary for the inhibition of
platelet aggregation.
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